Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

被引：0
|
作者：
Yanwen Yao
Dongmei Yuan
Hongbing Liu
Xiaoling Gu
Yong Song
机构：
[1] Jinling Hospital,Department of Respiratory Medicine
[2] Nanjing University School of Medicine,undefined
来源：
Cancer Immunology, Immunotherapy | 2013年 / 62卷
关键词：
Neutrophil to lymphocyte ratio; Prognostic factor; Tumor-related inflammation; Non-small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：471 / 479
页数：8
相关论文
共 50 条
  • [21] Evaluation of weight gain and overall survival of patients with advanced non-small cell lung cancer (NSCLC) treated with first-line platinum-based chemotherapy.
    Roeland, Eric
    Fintelmann, Florian J.
    Hilton, Fiona
    Tarasenko, Lisa
    Calle, Roberto A.
    Bonomi, Philip D.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] Correlation of apolipoprotein A-I kinetics with survival and response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer
    Ting Cheng
    Xin Dai
    Dan-Li Zhou
    Yang Lv
    Li-Yun Miao
    Medical Oncology, 2015, 32
  • [23] Correlation of apolipoprotein A-I kinetics with survival and response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer
    Cheng, Ting
    Dai, Xin
    Zhou, Dan-Li
    Lv, Yang
    Miao, Li-Yun
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 7
  • [24] Lymphocyte subsets predict clinical outcomes of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
    Liu, Y.
    Wang, J.
    Liu, L.
    Xu, X.
    Mi, X.
    Shao, M.
    Chen, D.
    Li, S.
    Xiao, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S890 - S890
  • [25] The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy
    Lee, Siow Ming
    Upadhyay, Sunil
    Lewanski, Conrad
    Falk, Stephen
    Skailes, Geraldine
    Woll, Penella J.
    Hatton, Matthew
    Lal, Rohit
    Jones, Richard
    Toy, Elizabeth
    Rudd, Robin
    Ngai, Yenting
    Edwards, Alex
    Hackshaw, Allan
    EUROPEAN JOURNAL OF CANCER, 2019, 120 : 86 - 96
  • [26] High glasgow prognostic score associates with a poor survival in Chinese advanced non-small cell lung cancer patients treated with platinum-based first-line chemotherapy
    Su, Keju
    Wang, Xu
    Chi, Lumei
    Liu, Yang
    Jin, Lina
    Li, Wei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (08): : 16353 - 16359
  • [27] The prognostic value of pretreatment albumin-to-fibrinogen ratio in small cell lung cancer patients receiving first-line platinum-based chemotherapy
    Li, Qi
    Li, Li
    Wang, Yuchao
    Xu, Chunhua
    Zou, Jue
    HELIYON, 2023, 9 (09)
  • [28] Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy
    Grossi, Francesco
    Genova, Carlo
    Rijavec, Erika
    Barletta, Giulia
    Biello, Federica
    Dal Bello, Maria Giovanna
    Meyer, Krista
    Roder, Joanna
    Roder, Heinrich
    Grigorieva, Julia
    LUNG CANCER, 2018, 117 : 64 - 69
  • [29] Bevacizumab (Avastin) in Combination with Platinum-Based Chemotherapy as First-Line Therapy for Advanced Non-Small Cell Lung Cancer in Different Age Groups in Germany
    Wirtz, H.
    Lang, S.
    Gessner, C.
    Krueger, S.
    Zortel, M.
    Heinzmann, S.
    Schuette, W.
    PNEUMOLOGIE, 2020, 74 : S16 - S16
  • [30] Correlation of C-Reactive Protein with Survival and Radiographic Response to First-Line Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer
    Wilop, Stefan
    Crysandt, Martina
    Bendel, Michael
    Mahnken, Andreas H.
    Osieka, Reinhard
    Jost, Edgar
    ONKOLOGIE, 2008, 31 (12): : 665 - 670
12345